CONNEQT Health, the leading consumer cardiovascular healthtech company, today announced the launch of a new On-Demand Assessment feature in the CONNEQT App – giving users instant access to a clinical-grade snapshot of their heart health.
Now available to all CONNEQT Pulse users on iOS, the On-Demand Assessment generates a physician-style, four-page cardiology report with the tap of a button. Designed to support early detection and informed decision-making, this new feature empowers individuals to better understand their cardiovascular status – without waiting for 30-day trend data.
“The On-Demand Assessment is a significant step forward in making preventive heart health more accessible,” said CONNEQT Health CEO, Craig Cooper. “Sometimes, people need answers now – not in 30 days. This feature delivers immediate, clinically validated insights that people can act on immediately.”
Key features of the On-Demand Assessment include:
- A clinical-grade analysis of key cardiovascular biomarkers – including central blood pressure, arterial stiffness, circulatory efficiency, and other biomarkers.
- A personalized cardiovascular risk summary, benchmarked against age-adjusted norms and clinical thresholds, with tailored lifestyle and medical recommendations.
- Instant report generation with PDF export, making it easy to share with healthcare providers or save for future reference.
While CONNEQT’s existing 30-Day Assessment offers deep insights through longitudinal trend analysis, the On-Demand Assessment serves as a valuable point-in-time check – ideal for onboarding new users, post-intervention follow-up, or periodic cardiovascular check-ins.
This launch reinforces CONNEQT’s commitment to delivering clinically meaningful, user-friendly tools that bridge the gap between consumer wellness and professional care. It also lays the foundation for future premium features, such as advanced analytics, ongoing monitoring, and physician-guided optimization, expanding the platform’s value for users and partners alike.
The On-Demand Assessment is now live in the latest version of the CONNEQT App on iOS, with Android availability coming soon.
CONNEQT Health (a Cardiex Limited company (ASX: CDX), is revolutionizing personal cardiovascular health through its groundbreaking CONNEQT Arterial Health Assessment, powered by the CONNEQT Pulse – the first and only FDA-cleared medical device for comprehensive at-home arterial health monitoring. Powered by over 20 years of cutting-edge, research-validated, and patented SphygmoCor® technology, the device provides advanced insights into vascular health by precisely measuring critical biomarkers such as arterial stiffness and central blood pressure. This innovative technology enables early detection of cardiovascular risks, empowering individuals with a proactive approach to heart health management through personalized cardiology reports and a user-friendly mobile app. By bridging advanced medical science with accessible home diagnostics, CONNEQT is transforming how individuals understand and monitor their cardiovascular wellness. For more information about this pioneering technology, visit www.conneqthealth.com
lindsay@lindsaystevenspr.com
LSPR
